OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
36
Results
Show all
Save search
Copy query
Show results for
Unknown
(36)
Publication Date
Release Date
2025
(11)
2022
(7)
2024
(6)
2021
(4)
2023
(3)
2020
(1)
2019
(1)
2016
(1)
2014
(1)
2011
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Interest of Youth Living With HIV in Long-Acting Antiretrovirals.
Not available
S-EPMC6331217
|
biostudies-literature
Cite
RHOA-dependent regulation of mitochondrial remodeling and cell motility in hypoxia-exposed gastric epithelial cells.
Not available
S-EPMC12377718
|
biostudies-literature
Cite
A Biologically Inert Tamoxifen-derived Long-lasting Hydrogel-mediated Immunochemotherapy Can Mitigate Tumour Progression and Activate T Cell Immunity.
Not available
S-EPMC12774480
|
biostudies-literature
Cite
Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis.
Not available
S-EPMC4731142
|
biostudies-literature
Cite
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019.
Not available
S-EPMC8860753
|
biostudies-literature
Cite
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
Not available
S-EPMC3111069
|
biostudies-literature
Cite
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Not available
S-EPMC4179097
|
biostudies-literature
Cite
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets